We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STRO icon
11626
CALL
Sutro Biopharma
STRO
$340M
$242K ﹤0.01%
1,300
-350
-21% -$68.5K
UBX
11627
DELISTED
Unity Biotechnology
UBX
$242K ﹤0.01%
5,220
-5,217
-50% -$251K
WHD icon
11628
PUT
Cactus
WHD
$5.88B
$242K ﹤0.01%
+6,600
New +$228K
ATRS
11629
PUT
DELISTED
Antares Pharma, Inc.
ATRS
$242K ﹤0.01%
55,400
+5,200
+10% +$21.2K
PEI
11630
PUT
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
$242K ﹤0.01%
6,473
-694
-10% -$22.6K
APEI icon
11631
American Public Education
APEI
$828M
$241K ﹤0.01%
8,481
-47,386
-85% -$1.43M
SCL icon
11632
PUT
Stepan Co
SCL
$1.48B
$241K ﹤0.01%
+2,000
New +$262K
FRBK
11633
DELISTED
Republic First Bancorp Inc
FRBK
$241K ﹤0.01%
60,506
+24,227
+67% +$97.3K
CALA
11634
CALL
DELISTED
Calithera Biosciences, Inc
CALA
$241K ﹤0.01%
5,755
-1,655
-22% -$72.7K
FBIO icon
11635
PUT
Fortress Biotech
FBIO
$97.7M
$240K ﹤0.01%
+4,487
New +$271K
INFI
11636
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$240K ﹤0.01%
80,247
-297,265
-79% -$940K
ODT
11637
CALL
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$240K ﹤0.01%
68,800
-16,600
-19% -$57K
TGP
11638
CALL
DELISTED
Teekay LNG Partners L.P.
TGP
$240K ﹤0.01%
15,900
+3,200
+25% +$48.6K
CYCN icon
11639
CALL
Cyclerion Therapeutics
CYCN
$17.7M
$239K ﹤0.01%
3,065
+2,045
+200% +$128K
GLDD
11640
DELISTED
Great Lakes Dredge & Dock
GLDD
$239K ﹤0.01%
16,368
-139,517
-89% -$2.06M
HIBS icon
11641
PUT
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$17.4M
$239K ﹤0.01%
+211
New +$267K
JBGS
11642
PUT
JBG SMITH
JBGS
$672M
$239K ﹤0.01%
7,600
-700
-8% -$22.8K
AONCW
11643
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$239K ﹤0.01%
+256,890
New +$205K
TZPSW
11644
DELISTED
TZP Strategies Acquisition Corp. Warrant
TZPSW
$239K ﹤0.01%
285,959
+782
+0.3% +$571
CFFN icon
11645
PUT
Capitol Federal Financial
CFFN
$1.08B
$238K ﹤0.01%
20,200
+2,100
+12% +$26.9K
DAO
11646
Youdao
DAO
$2.17B
$238K ﹤0.01%
10,288
-50,574
-83% -$1.22M
DSGX icon
11647
Descartes Systems
DSGX
$6.62B
$238K ﹤0.01%
3,439
-15,675
-82% -$991K
LXU icon
11648
CALL
LSB Industries
LXU
$737M
$238K ﹤0.01%
51,090
+14,950
+41% +$71.2K
MLI icon
11649
CALL
Mueller Industries
MLI
$14.6B
$238K ﹤0.01%
+22,000
New +$249K
RFIL icon
11650
PUT
RF Industries
RFIL
$148M
$238K ﹤0.01%
31,900
+12,600
+65% +$89K
464 465
466
467 468

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.